Blueprint Medicines Corporation (LON:0HOJ)

Blueprint Medicines Statistics

Total Valuation

LON:0HOJ has a market cap or net worth of GBP 6.21 billion. The enterprise value is 6.07 billion.

Market Cap	6.21B
Enterprise Value	6.07B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	64.73M
Shares Outstanding	n/a
Shares Change (YoY)	+4.21%
Shares Change (QoQ)	+4.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	60.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.26
PB Ratio	23.43
P/TBV Ratio	23.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-50.33
EV / Sales	14.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-51.94

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 2.08.

Current Ratio	2.80
Quick Ratio	2.62
Debt / Equity	2.08
Debt / EBITDA	n/a
Debt / FCF	-4.73
Interest Coverage	-2.44

Financial Efficiency

Return on equity (ROE) is -47.71% and return on invested capital (ROIC) is -11.09%.

Return on Equity (ROE)	-47.71%
Return on Assets (ROA)	-9.75%
Return on Invested Capital (ROIC)	-11.09%
Return on Capital Employed (ROCE)	-18.44%
Revenue Per Employee	635,147
Profits Per Employee	-175,960
Employee Count	649
Asset Turnover	0.50
Inventory Turnover	0.90

Taxes

In the past 12 months, LON:0HOJ has paid 1.42 million in taxes.

Income Tax	1.42M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.33%
50-Day Moving Average	118.27
200-Day Moving Average	99.37
Relative Strength Index (RSI)	81.11
Average Volume (20 Days)	841

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.97

Income Statement

In the last 12 months, LON:0HOJ had revenue of GBP 435.08 million and -120.53 million in losses. Loss per share was -1.90.

Revenue	435.08M
Gross Profit	419.77M
Operating Income	-134.91M
Pretax Income	-119.11M
Net Income	-120.53M
EBITDA	-122.57M
EBIT	-134.91M
Loss Per Share	-1.90

Balance Sheet

The company has 446.00 million in cash and 552.11 million in debt, giving a net cash position of 144.31 million.

Cash & Cash Equivalents	446.00M
Total Debt	552.11M
Net Cash	144.31M
Net Cash Per Share	n/a
Equity (Book Value)	264.81M
Book Value Per Share	4.10
Working Capital	349.44M

Cash Flow

In the last 12 months, operating cash flow was -112.66 million and capital expenditures -4.15 million, giving a free cash flow of -116.80 million.

Operating Cash Flow	-112.66M
Capital Expenditures	-4.15M
Free Cash Flow	-116.80M
FCF Per Share	n/a

Margins

Gross margin is 96.48%, with operating and profit margins of -31.01% and -27.70%.

Gross Margin	96.48%
Operating Margin	-31.01%
Pretax Margin	-27.38%
Profit Margin	-27.70%
EBITDA Margin	-28.17%
EBIT Margin	-31.01%
FCF Margin	n/a

Dividends & Yields

LON:0HOJ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.21%
Shareholder Yield	n/a
Earnings Yield	-1.94%
FCF Yield	-1.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HOJ has an Altman Z-Score of 1.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.93
Piotroski F-Score	3